{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T07:23:05Z","timestamp":1787383385723,"version":"build-2736575974"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Ophthalmology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the clinical efficacy of the Omidenepag isopropyl 0.002% ophthalmic solution (OMDI) (Eybelis, topical selective EP2 receptor agonist) for feline glaucoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animal Studied<\/jats:title>\n                    <jats:p>Eleven client\u2010owned cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Procedures<\/jats:title>\n                    <jats:p>The medical records of cats prescribed OMDI between August 2021 and February 2024 were reviewed. These eye drops were administered to feline eyes that were unresponsive to conventional anti\u2010glaucoma medications. Eyes responding to OMDI for \u2265\u20096, 1\u20136, and &lt;\u20091\u2009months were classified as long\u2010term responders, short\u2010term responders, and non\u2010responders, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>OMDI was administered BID\u2010QID to 12 eyes of 11 cats diagnosed with various glaucoma etiologies: primary glaucoma and secondary glaucoma (lens\u2010induced uveitis from Morgagnian cataract, aqueous misdirection syndrome, idiopathic anterior uveitis, anterior uveitis from systemic hypertension). The mean intraocular pressure immediately before OMDI administration was 53.6\u2009mmHg (range, 32\u201386\u2009mmHg). Five eyes retained vision, whereas seven were non\u2010visual. The patients were followed for an average duration of 337.4\u2009days (range, 28\u20131281\u2009days) after treatment initiation. Four, two, and six eyes were classified as long\u2010term responders, short\u2010term responders, and non\u2010responders, respectively. Four of the five eyes with vision before OMDI administration were classified as long\u2010term responders. Contrastingly, none of the blind eyes without vision before drug administration were classified as long\u2010term responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>OMDI could be an additional therapeutic option for feline glaucoma that is unresponsive to conventional therapies. Administration of OMDI following the early diagnosis of glaucoma is recommended to maximize therapeutic efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/vop.70047","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T05:44:47Z","timestamp":1753595087000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Clinical Efficacy of a Topical Selective EP2 Receptor Agonist Against Feline Glaucoma That Is Not Responsive to Conventional Anti\u2010Glaucoma Eyedrops"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-4700","authenticated-orcid":false,"given":"Jaesang","family":"Ahn","sequence":"first","affiliation":[{"name":"Dr. Ahn's Animal Eye Clinic  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajeong","family":"Jeong","sequence":"additional","affiliation":[{"name":"Dr. Ahn's Animal Eye Clinic  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"1665","volume-title":"Veterinary Ophthalmology","author":"Glaze M. B.","year":"2021"},{"key":"e_1_2_10_3_1","first-page":"3195","article-title":"Prostanoid\u2010Induced Relaxation of Precontracted Cat Ciliary Muscle Is Mediated by EP2 and DP Receptors","volume":"33","author":"Chen J.","year":"1992","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_10_4_1","first-page":"1188","article-title":"Characterization of Ciliary Muscle Relaxation Induced by Various Agents in Cats","volume":"36","author":"Goh Y.","year":"1995","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/vop.12292"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.1991.52.03.436"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-5224.2007.00583.x"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/vop.12679"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-5224.2011.00913.x"},{"key":"e_1_2_10_10_1","unstructured":"G. J.McLellan T.\u2010L.Lin S.Hildreth et\u00a0al. \u201cDiurnal Intraocular Pressure and Response to Topically Administered 1% Brinzolamide in a Spontaneous Feline Model of Primary Congenital Glaucoma (Abstract) \u201d Annual Meeting of the Association for Research in Vision and Ophthalmology Fort Lauderdale (2009)."},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.661"},{"key":"e_1_2_10_12_1","first-page":"1475","article-title":"Expression and Localization of FP and EP Prostanoid Receptor Subtypes in Human Ocular Tissues","volume":"43","author":"Schl\u00f6tzer\u2010Schrehardt U.","year":"2002","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1988.4.13"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1627"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.02.015"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2800"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.593725"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22745"},{"key":"e_1_2_10_19_1","first-page":"588","article-title":"Comparison of the Hypotensive and Other Ocular Effects of Prostaglandins E2 and F2 Alpha on Cat and Rhesus Monkey Eyes","volume":"22","author":"Stern F. A.","year":"1982","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_10_20_1","first-page":"312","article-title":"Long\u2010Term Maintenance of Reduced Intraocular Pressure by Daily or Twice Daily Topical Application of Prostaglandins to Cat or Rhesus Monkey Eyes","volume":"24","author":"Bito L. Z.","year":"1983","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_10_21_1","first-page":"376","article-title":"Noninvasive Observations on Eyes of Cats After Long\u2010Term Maintenance of Reduced Intraocular Pressure by Topical Application of Prostaglandin E2","volume":"24","author":"Bito L. Z.","year":"1983","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_10_22_1","first-page":"1257","article-title":"Marked Species Differences in the Pharmacology of Prostanoid Induced Ocular Hypotension","volume":"32","author":"Woodward D. F.","year":"1991","journal-title":"ARVO Abstracts. Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S340386"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.06.003"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2024.02.010"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002321"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2021.0122"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-5224.2011.00912.x"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/030098589002700105"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.2002.tb11292.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-5224.2008.00614.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2000.61.1220"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-5224.2005.00397.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-5224.2005.00435.x"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0076"}],"container-title":["Veterinary Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vop.70047","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vop.70047","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vop.70047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:29:34Z","timestamp":1787380174000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vop.70047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/vop.70047"],"URL":"https:\/\/doi.org\/10.1111\/vop.70047","archive":["Portico"],"relation":{},"ISSN":["1463-5216","1463-5224"],"issn-type":[{"value":"1463-5216","type":"print"},{"value":"1463-5224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"2025-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70047"}}